|
Market Closed -
Nasdaq
21:00:00 25/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.360 USD | -4.90% |
|
-19.53% | -67.31% |
| 09-14 | Dogwood Therapeutics Completes Enrollment In Halneuron Phase 2b Chemotherapy Induced Neuropathic Pain Trial | CI |
| 09-01 | Dogwood Therapeutics, Inc. - Special Call |
| Market Cap | 46.23M 40.57M 38.31M 34.92M 65.36M 4.43B 65.83M 458M 178M 2.26B 174M 170M 7.28B | P/E 2026 * |
-1.55x | P/E 2027 * | -2.14x |
|---|---|---|---|---|---|
| Enterprise Value | 46.23M 40.57M 38.31M 34.92M 65.36M 4.43B 65.83M 458M 178M 2.26B 174M 170M 7.28B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
27.42% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| DWTX | Delayed | |
CBOE
| DWTX | Real-time |
Last Transcript: Dogwood Therapeutics, Inc.
| 1 day | -4.90% | ||
| 1 week | -19.53% | ||
| Current month | -47.29% | ||
| 1 month | -48.87% | ||
| 3 months | -17.58% | ||
| 6 months | -34.62% | ||
| Current year | -67.31% |
| 1 week | 1.34 |  | 1.76 |
| 1 month | 1.34 | | 2.74 |
| Current year | 1.28 | | 4.34 |
| 1 year | 1.28 | | 9.5 |
| 3 years | 1.28 | | 29.28 |
| 5 years | 1.28 | | 227.77 |
| 10 years | 1.28 | | 417.75 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 05/03/26 | Free | Chief Technology Officer | 82,500 | 0.2478% | ||
| 05/03/26 | Free | Chief Financial Officer | 82,500 | 0.2478% | ||
| 05/03/26 | Free | Chief Executive Officer | 330,000 | 0.9911% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.90% | -19.53% | -75.36% | -94.21% | 46.23M | |
| -3.30% | +1.50% | +57.79% | +99.14% | 72.26B | |
| +1.25% | -3.01% | +37.83% | +87.66% | 60.24B | |
| +2.12% | +5.26% | +35.69% | +23.40% | 27.73B | |
| -3.06% | -1.81% | -14.01% | +357.24% | 25.73B | |
| -0.75% | +2.56% | +0.45% | -3.28% | 24.75B | |
| +0.40% | +0.75% | +23.72% | -11.33% | 20.74B | |
| -1.70% | -2.12% | +150.24% | +326.97% | 15.06B | |
| +0.36% | -0.34% | +48.98% | +167.40% | 14.41B | |
| +0.21% | +1.17% | -3.95% | +512.06% | 14.23B | |
| Average | -0.94% | -1.56% | +26.14% | +146.50% | 27.52B | |
| Weighted average by Cap. | -0.77% | +0.31% | +38.14% | +132.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -29.57M -25.95M -24.5M -22.33M -41.8M -2.83B -42.1M -293M -114M -1.45B -111M -109M -4.65B | -23.82M -20.9M -19.74M -17.99M -33.68M -2.28B -33.92M -236M -91.5M -1.17B -89.44M -87.5M -3.75B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/09/26 | US$1.360 | -4.90% | 46,398 |
| 24/09/26 | US$1.430 | -5.30% | 17,169 |
| 23/09/26 | US$1.510 | 0.00% | 23,693 |
| 22/09/26 | US$1.510 | -5.63% | 128,219 |
| 21/09/26 | US$1.600 | -5.33% | 61,684 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DWTX Stock
Select your edition
All financial news and data tailored to specific country editions
